Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 130 participants.

Also called NCT01151176

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01151176
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Brazil (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT01151176. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
Condition
Acute Coronary Syndrome
Intervention (Drug)
Regular Insulin
Intervention (Drug)
Regular Insulin
Lead sponsor
Universidade Positivo (class: other)
Collaborator
Emory University (class: other)

Record details

Record id
cardio:ct-nct01151176
Content hash
d1932fe83ac02b81d45f224d325ae2580b7af56547a68b51440d7cabf2d47804